Can a new diabetes drug also treat heart disease?



Medical News Bulletin | Health News and Medical Research – Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Dapagliflozin, a drug originally developed to treat diabetes, shows benefit in patients in heart failure. Dapagliflozin belongs to a relatively new class of drugs, the sodium-glucose co-transporter-2 inhibitors, for treating type 2 diabetes mellitus. This new class of drugs works to reduce blood glucose levels by reducing the reabsorption of glucose in the kidneys. Clinical […]

The post Can a new diabetes drug also treat heart disease? appeared first on Medical News Bulletin | Health News and Medical Research.



Source link

Leave a Reply!

So glad to see you sticking around!

Want to be the first one to receive the new stuff?

Enter your email address below and we'll send you the goodies straight to your inbox.

Thank You For Subscribing!

This means the world to me!

Spamming is not included! Pinky promise.